Interferon β therapy increases serum ferritin levels in patients with relapsing-remitting multiple sclerosis

Abstract

Serum ferritin levels have been found to be increased in patients with active progressive multiple sclerosis (MS). However, its levels are reported to be unchanged in stable and in active relapsing-remitting (RR) form of the disease. No research to date has assessed the influence of interferon β (IFN-β) on ferritin concentrations. In this study, serum ferritin levels were measured in 43 individuals with RR-MS and 38 age- and sex-matched control volunteers. There were no significant differences between controls and patients under stable and untreated conditions. In patients at 12 months after the beginning of IFN-β therapy, ferritin levels were higher in women and in men, in comparison with baseline (71.4 ± 58.6 vs 43.4 ± 29.9 ng/mL, P = 0.0006 and 216.0 ± 124.3 vs 127.8 ± 74.9 ng/mL, P = 0.0022, respectively). These results suggest that larger prospective studies are required to evaluate the role of serum ferritin in MS and its potential usefulness in monitoring responses to immunomodulatory therapies.

Keywords

multiple sclerosis ferritin iron metabolism interferon beta

Get full access to this article

View all access options for this article.

References

1 Le Vine SM Lynch SG Ou C-N Wulser MJ Tam E Boo N . Ferritin, transferrin and iron concentrations in the cerebrospinal fluid of multiple sclerosis patients. Brain Res 1999; 821: 511 – 515 .

2 Sfagos C Makis AC Chaidos A Hatsimichael EC Dabmaga A Kosma K . Serum ferritin, transferrin and soluble tranferrin receptor levels in multiple sclerosis patients. Mult Scler 2005; 11: 272 – 275 .

3 Exley C Mamutse G Korchazhkina O Pye E Strekopytov S Polwart A . Elevated urinary excretion of aluminium and iron in multiple sclerosis. Mult Scler 2006; 12: 533 – 540 .

4 Otterbein LE Soares MP Yamashita K Bach FH . Heme, oxygenase-1: undeashing the protective properties of heme. Trends Immunol 2003; 24: 449 – 455 .

5 Novotny L Vitek L . Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp Biol Med 2003; 228: 568 – 571 .

6 Williams MJA Poulton R Williams S . Relationship of serum ferritin with cardiovascular risk factors and inflammation in young men and women. Atherosclerosis 2002; 165: 179 – 184 .

7 Wolff B Volzke H Ludemann J Robinson D Vogelgesang D Staudt A . Association between high serum ferritin levels and carotid atherosclerosis in the study of health in Pomerania (SHIP). Stroke 2004; 35: 453 – 457 .

8 Torti FM Torti SV . Regulation of ferritin genes and protein. Blood 2002; 99: 3505 – 3516 .

9 Mehindate K Sahlas DJ Frankel D Mawal Y Liberman A Corcos J . Proinflammatory cytokines promote glial heme oxygenase-1 expression and mitochondrial iron deposition: implications for multiple sclerosis. J Neurochem 2001; 77: 1386 – 1395 .

10.

10 Chakrabarty A Emerson MR Le Vine SM . Heme oxygenase-1 in SJL mice with experimental allergic encephalomyelitis. Mult Scler 2003; 9: 372 – 381 .

11.

11 Ren H Leib SL Ferniero DM Tauber MG Chisten S . Induction of haeme oxygenase-1 causes cortical non-haeme iron increase in experimental pneumococcal meningitis: evidence that concomitant ferritin up-regulation prevents iron-induced oxidative damage. J Neurochem 2007; 100: 532 – 544 .

12.

12 Le Vine SM Maiti S Emerson MR Pedchenko TV . Apoferritin attenuates experimental allergic encephalomyelitis in SJL mice. Dev Neurosci 2002; 24: 177 – 183 .

13.

13 Mitchell KM Dotson AL Cool KM Chakrabarty A Benedict SH LeVine SM . Deferiprone, an orally deliverable iron chelator, ameliorates experimental autoimmune encephalomyelitis. Mult Scler 2007; 13: 1118 – 1126 .

14.

14 Hofer H Osterreicher C Jessner W Penz M Steindl-Munda P Wrba F . Hepatic iron concentration does not predict response to standard and pegylated-IFN/ribavirin therapy in patients with chronic hepatitis C. J Hepatol 2004: 40; 1018 – 1022 .